Verona Pharma Plc

This study is testing a new inhaled combination medicine for people with Chronic Obstructive Pulmonary Disease (COPD). Researchers want to see if combining two drugs (ensifentrine and glycopyrrolate) works better than either drug alone or a placebo at improving lung function. Abo…

This study is testing whether a new inhaled medicine called ensifentrine can reduce harmful inflammation in the lungs of people with COPD. 56 participants with moderate to severe COPD will use the medicine or a placebo inhaler twice daily for 8-week periods, with researchers meas…

This study is testing whether an inhaled medicine called ensifentrine can help control a chronic lung disease called bronchiectasis. About 180 adults with this condition will use a nebulizer twice daily for at least 24 weeks, receiving either the real medicine or a placebo. The m…